Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
-521K
-
Total reported value, excl. options
-
$314M
-
Value change
-
-$2.63M
-
Put/Call ratio
-
0.11
-
Number of buys
-
36
-
Number of sells
-
-27
-
Price
-
$9.80
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q3 2021
104 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q3 2021.
AVADEL PHARMACEUTICALS - COM (AVDL) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.74M shares), BRANDES INVESTMENT PARTNERS, LP (3.25M shares), Vivo Capital, LLC (2.94M shares), Polar Capital Holdings Plc (2.79M shares), COWEN AND COMPANY, LLC (2.53M shares), Avoro Capital Advisors LLC (2.28M shares), GENDELL JEFFREY L (2.06M shares), Woodline Partners LP (1.73M shares), FRAZIER MANAGEMENT LLC (952K shares), and RENAISSANCE TECHNOLOGIES LLC (853K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.